Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Kisspeptin is a key regulator of the hypothalamic–pituitary–gonadal axis, controlling puberty and fertility; kisspeptin-10 also inhibits trophoblast invasion and tumor metastasis in experimental models339199, Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487.
While Kisspeptin works as a family of peptides (eg, kisspeptin-10, -13, -14, -54) derived from the KISS1 precursor that activate G-protein–coupled receptor KISS1R (GPR54), triggering GnRH release and regulating pubertal onset and reproductive axis activity339199, Thymosin Alpha-1 is a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414.
Kisspeptin
KISS1
Thymosin Alpha-1
PTMA
Kisspeptin and Thymosin Alpha-1 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Kisspeptin is more often discussed in the realm of Reproductive health, whereas Thymosin Alpha-1 is more often associated with the realm of Immunology and inflammation and Oncology. They also influence different molecular systems, with Kisspeptin tracking more closely to GPCR receptor while Thymosin Alpha-1 centers more on Toll-like receptor. Both come from biologically derived origins and their development context also differs, with Kisspeptin in Preclinical development while Thymosin Alpha-1 is approved. Kisspeptin carries amidation features, while Thymosin Alpha-1 instead reflects acetylation changes, while their sequence patterns also diverge, with Kisspeptin showing alpha-helical domain features and Thymosin Alpha-1 showing protein-mimetic sequence features.